Etirinotecan pegol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Etirinotecan pegol
Accession Number
DB14951
Type
Small Molecule
Groups
Investigational
Description

Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma).

Synonyms
Not Available
External IDs
NKTR-102
Categories
UNII
LJ16641SFT
CAS number
848779-32-8
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Nektar_Therapeutics
ATC Codes
L01XX56 — Etirinotecan pegol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentCancer, Advanced / Metastatic Solid Tumors1
2CompletedTreatmentAnaplastic Astrocytoma (AA) / Anaplastic Oligodendroglioma (AO) / Glioblastomas (GBM)1
2CompletedTreatmentCancer of the Ovary / Tumors1
2CompletedTreatmentCancer, Breast / Tumors1
2CompletedTreatmentColorectal Cancers1
2CompletedTreatmentMalignant Solid Tumours1
2CompletedTreatmentMetastatic Non Small Cell Lung Cancer / Recurrent Non Small Cell Lung Cancer1
3CompletedTreatmentLocally Recurrent Breast Cancer / Metastatic Breast Cancer (MBC)1
3RecruitingTreatmentCancer, Breast / Metastasis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:37 / Updated on May 21, 2019 12:32